{"id":342643,"date":"2026-11-09T13:34:02","date_gmt":"2026-11-09T08:04:02","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=342643"},"modified":"2026-11-09T13:34:02","modified_gmt":"2026-11-09T08:04:02","slug":"sparc-share-price-surges-11-percent-9-november-2026-why-sun-pharma-advanced-research-shares-rise-despite-weak-market","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sparc-share-price-surges-11-percent-9-november-2026-why-sun-pharma-advanced-research-shares-rise-despite-weak-market\/","title":{"rendered":"SPARC Share Price Surges Up to 11% on 9 November 2026: Why Sun Pharma Advanced Research Shares Rose Despite Weak Sentiment on D-Street and What to Check"},"content":{"rendered":"

SPARC rose up to 11% on 9 Nov 2026 to Rs 219.49 vs a Rs 197.03 close (Mint). No company news found; Q2 loss narrowed, and a P\/E near 4 reflects a one-off gain, not a measure of value.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The SPARC share price rose as much as 11% on 9 November 2026, touching Rs 219.49 against a Rs 197.03 close, per Mint, while Sun Pharma Advanced Research shares beat a weak market. I found no company announcement for the day, so the causes below are possibilities, not confirmed facts.<\/p>\n<\/p><\/div>\n

The SPARC share price<\/strong> rose as much as 11% on 9 November 2026 even as the broader market stayed weak, and Sun Pharma Advanced Research shares<\/strong> touched an intraday high of Rs 219.49. Mint asks what is boosting the medical stock. This article sets out the price data, the possible reasons, the latest quarterly numbers, the drug pipeline, valuation and risks. I did not find a company filing for 9 November, so I separate what is reported from what is guesswork.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n